Statera Biopharma, Inc. Operating Lease, Expense
Statera Biopharma, Inc. reported Operating Lease, Expense of $185.71 thousand for the 12-month period ending 2021-12-31, per its 10-K filed 2022-10-06.
Discontinued › Expense Statement › Operating Expenses
us-gaap:OperatingLeaseExpense · last filed 2022-10-06
- Statera Biopharma, Inc. operating lease, expense for the quarter ending 2021-12-31 was $81.75K.
- Statera Biopharma, Inc. operating lease, expense for the quarter ending 2020-12-31 was $0.00.
- Statera Biopharma, Inc. operating lease, expense for fiscal 2021 was $185.71K, a 5448.64% increase from fiscal 2020.
- Statera Biopharma, Inc. operating lease, expense for fiscal 2020 was $3.35K, a 98.35% decline from fiscal 2019.
- Statera Biopharma, Inc. operating lease, expense for fiscal 2019 was $202.89K, a 49.07% decline from fiscal 2018.
- Statera Biopharma, Inc. operating lease, expense for fiscal 2018 was $398.35K.
| Period end | Operating Lease, Expense 3 month | Operating Lease, Expense 9 month | Operating Lease, Expense 12 month | Operating Lease, Expense 12 month as first filed |
|---|---|---|---|---|
| 2021-12-31 | $81.75K derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $185.71K 10-K · filed 2022-10-06 | ||
| 2021-09-30 | $103.96K 10-Q · filed 2021-11-15 | |||
| 2020-12-31 | $0.00 derived: 10-K 12 month − 10-Q 9 month · filed 2022-10-06 | $3.35K 10-K · filed 2022-10-06 | $19.29K 10-K · filed 2021-03-22 | |
| 2020-09-30 | $3.35K 10-Q · filed 2021-11-15 | |||
| 2019-12-31 | $202.89K 10-K · filed 2021-03-22 | $209.50K 10-K · filed 2020-04-15 | ||
| 2018-12-31 | $398.35K 10-K · filed 2020-04-15 |